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Abstract. 
 
Trypanosoma brucei
 
 is lysed by tumor necro-
 
sis factor-
 
a
 
 (TNF-
 
a
 
) in a dose-dependent way, involv-
ing specific binding of the cytokine to a trypanosomal 
glycoprotein present in the flagellar pocket of the para-
site. TNF-
 
a
 
–gold particles are endocytosed via coated 
pits and vesicles and are directed towards lysosome-like 
digestive organelles. The specific uptake of the cyto-
kine by the parasite results in a developmentally regu-
lated loss of osmoregulatory capacity. TNF-
 
a
 
 specific 
lysis is prevented when lysis assays are performed at a 
temperature 
 
,
 
26
 
8
 
C, despite uptake of the cytokine. In-
hibition of lysis is also observed when a lysosomotropic 
agent is added during the first 2 h of incubation. Both 
monomorphic and pleomorphic trypanosomes are ly-
sed but only when isolated during the peak of parasi-
taemia. Lysis is not observed with early infection stage 
parasites or procyclic (insect-specific) forms. Anti–
TNF-
 
a
 
 treatment of 
 
T. brucei
 
-infected mice reveals a 
dramatic increase in parasitaemia in the blood circula-
tion, the spleen, the lymph nodes, and the peritoneal 
cavity. These data suggest that in the mammalian host, 
TNF-
 
a
 
 is involved in the growth control of 
 
T. brucei.
 
A
 
frican
 
 trypanosomes are extracellular parasitic pro-
tozoa, transmitted by the bite of the tsetse fly (44).
 
Trypanosoma brucei brucei
 
, 
 
Trypanosoma vivax
 
and 
 
Trypanosoma congolense
 
 are the causative agents of
Nagana, a cattle disease similar to sleeping sickness, caused
in humans by 
 
Trypanosoma brucei gambiense
 
 and 
 
Trypano-
soma brucei rhodesiense.
 
 All these parasites need to sur-
vive a long time exposure to the immune system of their
mammalian host, as they multiply predominantly in the
bloodstream. Hence, well equilibrated growth regulation
systems must exist, allowing the parasite to survive suffi-
ciently long without killing its mammalian host, to ensure
an effective transmission of the species. Such a system in-
volves the variant-specific surface glycoprotein (VSG),
 
1
 
which is the major surface antigen and acts as a protective
coat for the parasite (8, 28). During the ascending parasi-
taemia, the majority of the dividing parasites (e.g., long
slender forms) belong to the same antigenic type, called
the homotype. A peak of parasitaemia is reached when
long slenders differentiate into nondividing, short stumpy
forms, which have a relatively short in vivo half life of 24–
36 h and release VSGs in the circulation upon degenera-
tion (5). These degenerating parasites allow the host to de-
velop an antibody response to the homotype (34). Subse-
quently, the parasitaemia enters a descending phase as try-
panosomes of the major variable antigen type (VAT) are
eliminated. In contrast to the homotype VAT, spontane-
ous arising minor VATs or heterotypes continue to multi-
ply during the descending phase of the parasitaemia. One
of these VATs will overgrow the others and become the
new homotype, giving rise to a new peak of parasitaemia
(43). Although an effective anti-VSG response allows the
host to regularly eliminate excessive numbers of parasites
through phagocytosis of opsonized parasites (11), resis-
tance and survival time of different mice strains cannot be
directly correlated to the antibody response. Combined re-
sults from studies using different trypanosome strains in
both resistant and susceptible mice, as well as their F1 de-
scendants, showed that the ability to produce antibodies to
the first variant antigen population is inherited as a domi-
nant trait, while survival time during trypanosomiasis is in-
herited as a recessive trait (10, 33). Other in vivo studies
have shown that by artificial control of the height of the
parasitaemia level, susceptible mice become capable of clear-
ing trypanosome infections (9), while irradiation of mice
before infection does not influence the height of parasi-
taemia plateau (32). Collectively, these observations favor
the hypothesis that factors other than the anti-VSG re-
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sponse may contribute to the control of the parasitaemia.
Recently it has become clear that growth control of trypano-
somes involves specific immunoregulatory molecules.
Both EGF (15) and interferon gamma (IFN-
 
g
 
; 27) were
shown to enhance the growth of 
 
Trypanosoma brucei.
 
 As
IFN-
 
g
 
 synthesis was shown to be induced during trypano-
somiasis, this growth regulation can be considered as ac-
tive. Another cytokine shown to be induced during trypano-
some infections is tumor necrosis factor-
 
a
 
 (TNF-
 
a
 
; 16), a
cytokine mainly produced by activated macrophages (42).
Although the name of this cytokine is derived from its ca-
pacity to cause hemorragic necrosis of certain parenchy-
mal organs and certain tumors, the molecule was initially
isolated from the serum of 
 
T. brucei
 
–infected rabbits as a
factor called “cachectin,” responsible for systemic suppres-
sion of lipoprotein lipase activity and trypanosome-induced
cachectia (4, 29). In recent years TNF-
 
a
 
 was found to be
involved in the pathology of several parasitic diseases, in-
cluding trypanosomiasis (24), Chagas’ disease (39), leish-
maniasis (40), schistosomiasis (1), and malaria (19), and in
many of these cases this cytokine plays a bidirectional role
(41). We have recently reported a direct interaction be-
tween TNF-
 
a
 
 and 
 
T. brucei
 
, mediated by the lectin-like
domain of the cytokine (25). This domain was mapped at
the upper side of the TNF-
 
a
 
 molecule (determined the
TIP domain) and found to be functionally and spatially dis-
tinct from the mammalian TNF-
 
a
 
 receptor binding site. In
this study we show that in vitro, TNF-
 
a
 
 exerts a tempera-
ture- and pH-dependent lytic effect on certain develop-
mental stages of 
 
T. brucei
 
, involving the loss of osmo-
regulatory capacity. Furthermore the physiological relevance
of these in vitro findings is confirmed by demonstrating a
controlling role of TNF-
 
a
 
 on parasite development in vivo.
 
Materials and Methods
 
Parasites
 
Two clonal lines of 
 
T. brucei AnTat 1.1
 
 were used in all experiments. The
first 
 
AnTat 1.1
 
 line produces a pleomorphic infection in laboratory ro-
dents and was kindly provided to us by Dr. N. Van Meirvenne (Institute of
Tropical Medicine, Antwerp, Belgium). The second 
 
AnTat 1.1
 
 line used
produces a monomorpic infection and was obtained by syringe passing the
parasite. For analysis of the in vivo parasitaemia of 
 
T. brucei
 
, F1 mice
(C57bl6 X BALB/c) were infected with 5 
 
3
 
 10
 
3
 
 parasites. The number of
trypanosomes present in the blood was counted every 2 d using a light mi-
croscope.
For in vitro TNF-
 
a
 
–mediated lysis experiments and TNF-
 
a
 
–gold bind-
ing and uptake experiments, trypanosomes were grown in F1 mice to 10
 
7
 
or 2 
 
3
 
 10
 
8
 
 cells/ml of blood for the pleomorphic line and 10
 
7
 
 or 10
 
9
 
 cells/ml
blood for the monomorphic line. Whole blood was collected and diluted
in an equal volume of PBS (pH 8.0) supplemented with 1% glucose (PSG)
and 200 U heparin (Sigma Chemical Co., St. Louis, MO). Trypanosomes
were separated from blood by DE52 chromatography (22), using PSG, pH
8.0, for equilibration and elution. Further in vitro incubation was per-
formed in the equilibration buffer. Procyclic EATRO 1125 
 
AnTat 1.1
 
 try-
panosomes were cultured in vitro and incubated in the PSG equilibration
buffer during all in vitro experiments.
 
Preparation of Trypanosome Lysate
 
Washed DE52 purified trypanosomes were resuspended in PSG, pH 8.0,
to a final cell density of 2 
 
3
 
 10
 
8
 
/ml. Total cell lysate was obtained by three
freezing/thawing cycles in the presence of 1 mM Pefablock
 
®
 
 protease in-
hibitor (Boehringer Mannheim Corp., Mannheim, Germany). The total
protein concentration of the lysate was determined by the BioRad deter-
gent compatible protein assay kit (BioRad, Hercules, CA).
Endoglycosidase digestion of total lysate was performed with recombi-
nant 
 
Flavobacterium meningosepticum
 
 N-glycosidase F (Boehringer Mann-
heim Corp.) using 5 U/ml in PBS, pH 8.0. The digestion was performed
during 24 h at 37
 
8
 
C and followed by dialysis against PSG.
 
Recombinant Murine TNF-
 
a
 
Commercially available recombinant murine TNF-
 
a
 
 was supplied in 50 mM
Tris/acetate, pH 7.0, 350 mM NaCl, sterile filtered (0.22 mm) without ad-
dition of preservatives, and was kindly provided by Innogenetics NV
(Gent, Belgium). The protein concentration was 1,200 
 
m
 
g/ml as deter-
mined by means of UV protein measurement using 1.62 as extinction co-
efficient for a 1 mg/ml solution. The cytokine purity was 
 
.
 
98%, as deter-
mined by SDS-PAGE analysis under nonreducing conditions, using both
silver and Coomassie brilliant blue staining. The biological activity, deter-
mined with the mouse Lewis lung carcinoma cell line L929, was 2.3 
 
3
 
 10
 
8
 
U/mg. Endotoxin levels were 
 
,
 
0.25 EU/
 
m
 
g as determined by kinetic
quantitative chromogenic LAL assay using an 
 
Escherichia coli
 
 standard,
standardized against the EC-5 reference standard.
 
Trypanolysis Assays
 
All lysis assays analyzed by light microscopy were performed with DE52-
purified trypanosomes, washed, and resuspended in PSG (pH 8.0) to a fi-
nal cell density of 2 
 
3
 
 10
 
6
 
/ml. 100 
 
m
 
l of the suspension was mixed with 50
 
m
 
l of different TNF-
 
a
 
/PSG dilutions and 50 
 
m
 
l PSG in a 96-well flat bot-
tom culture plate. The percentage of lysis was calculated using light mi-
croscopy counts of remaining parasites after TNF-
 
a
 
 incubations, com-
pared to the counts of remaining parasites incubated for the same period
of time in the absence of TNF-
 
a
 
. Background lysis, i.e., lysis of trypano-
somes within 5 h of incubation at 30
 
8
 
C in the absence of TNF-
 
a
 
, never ex-
ceeded 5%. Light microscopy images from a BX50 microscope (Olympus
Corp., Tokyo, Japan) were photographed on Agfapan 100 ASA film
(Agfa-Gevaert AG, Leverküsen, Germany).
To analyze dose- and stage-dependent, TNF-
 
a
 
–mediated lysis, trypano-
somes were incubated at 30
 
8
 
C for up to 8 h in the presence of different fi-
nal concentrations of TNF-
 
a
 
, ranging from 1 to 10
 
6
 
 U/ml. Every hour the
survival of the parasites was calculated by counting the remaining para-
sites in the presence and absence of TNF-
 
a
 
.
To examine temperature-dependent, TNF-
 
a
 
–mediated lysis, incuba-
tions were performed at different indicated temperatures in the presence
of 10
 
4
 
 U/ml TNF-
 
a
 
, up until the moment that the percentage of lysis
reached its maximal level.
To analyze the relation between TNF-
 
a
 
 uptake and TNF-
 
a
 
–mediated
lysis, trypanosomes were incubated for 1 h at 17
 
8
 
 or 21
 
8
 
C in the presence
of 10
 
4
 
 U/ml TNF-
 
a
 
, washed, and incubated for another 4 h at 30
 
8
 
C. In the
reverse experimental setting, trypanosomes were incubated with TNF-
 
a
 
for 1 h at 30
 
8
 
C, washed, and further incubated at 17
 
8
 
 or 21
 
8
 
C. Control par-
asites were incubated for 1 h with TNF-
 
a
 
 at 17
 
8
 
, 21
 
8
 
, or 30
 
8
 
C, washed, and
subsequently further incubated at the initial incubation temperature.
Inhibition lysis experiments were performed for up to 5 h at 30
 
8
 
C in the
presence of 10
 
4
 
 U/ml TNF-
 
a
 
 and different concentrations of NH
 
4
 
Cl (0.1–
mM). Concentrations of NH
 
4
 
Cl 
 
.
 
5 mM were toxic during long periods of
incubation.
The neutralizing capacity of anti-TIP/TNF antibodies on TNF-
 
a
 
–medi-
ated trypanolysis was analyzed by preincubation of TNF-
 
a
 
 for 1 h with 10
 
m
 
g/ml of the tested monoclonal and polyclonal antibodies.
For transmission electron microscopy (TEM) analysis of TNF-
 
a
 
–medi-
ated lysis, monomorphic trypanosomes, isolated at the peak of the parasi-
taemia, were washed and resuspended in PSG (pH 8.0) supplemented
with 10
 
5
 
 U/ml TNF-
 
a
 
, to a final cell density of 5 
 
3
 
 10
 
7
 
/ml. After various
periods of incubation at 30
 
8
 
C, parasites were pelleted by centrifugation at
1,000 
 
g
 
 for 10 min and washed two times with cold PSG followed by one
wash in cold cacodylate buffer (pH 7.2). Subsequently, parasites were
fixed overnight at 4
 
8
 
C in cacodylate buffer containing 2.5% gluteralde-
hyde. After two washes in cacodylate buffer, the cells were fixed in 2%
OsO
 
4
 
 in the same buffer, wrapped in agar, dehydrated in ethanol, and em-
bedded in Epon. Ultrathin sections were floated on uranyl acetate and
lead citrate solution before being observed in an AEI 6B electron micro-
scope at 60 kV. Samples analyzed in TEM were analyzed in parallel in for-
ward scatter (FSC), using a FACStar
 
®
 
 (Becton Dickinson, San Jose, CA)
with a forward amplification gain of 16. At regular time intervals, parasite
samples were checked under a light microscope to calculate the percent-
age of trypanolysis. The obtained values were compared with the values
obtained by subtracting the FACS
 
®
 
 profile of control parasites from the 
Magez et al. 
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FACS® profile obtained after TNF-a incubations. Both calculation meth-
ods gave comparable results.
L929 Lysis Assays
Lewis lung carcinoma L929 cells were cultured in RPMI 1640 medium
supplemented with 10% heat inactivated FCS, l-glutamin (0.3 mg/ml), peni-
cillin (100 U/ml), and streptomycin (0.1 mg/ml), all obtained from GIBCO
BRL/Life Technologies (Gaithersburg, MD). To analyze TNF-a–mediated
lysis, cells were treated with actinomycin D (1 mg/ml) at a concentration
of 2 3 106 cells/ml. 100 ml of the suspension was mixed with 50 ml of differ-
ent TNF-a/medium dilutions and 50 ml medium in 96-well flat bottom cul-
ture plates. After 18 h of culture in a humid incubator, at 378C and a 5%
CO2 atmosphere, viability of the cells was assessed by dye uptake analysis.
Medium was decanted from the plates and cells were stained for 10 min
with 0.5% solution of crystal violet dissolved in a 1:5 mixture of methanol/
water. Plates were rinsed extensively in distilled water, and dye uptake was
assessed at 450 nm with a Titertek Multiscan MCC 340 ELISA Reader
(Flow Laboratories, McLean, VA). The neutralizing capacity of the anti-
TNF/TIP antibodies was analyzed by preincubation of TNF-a for 1 h at
378C with 10 mg/ml of the tested monoclonal or polyclonal antibodies.
125I-TNF-a Binding Assays
Purified recombinant TNF-a (100 mg) was labeled with 125I by the
chloramine-T method (17) and then filtered on Sephadex G-25. Blood-
stream and procyclic forms of T. brucei (108 cells/ml) were incubated at
48C with 125I-TNF-a in 1 ml PSG equilibration buffer (pH 8.0) supple-
mented with 1% BSA. After 6 h of incubation with gentle shaking, the try-
panosomes were washed five times with ice-cold PSG. The cell associated
radioactivity was measured in a g-counter. Nonspecific binding was deter-
mined as the amount of 125I-TNF-a bound in the presence of 100-fold ex-
cess unlabeled TNF-a. It ranged from 15 to 30% of total binding. A simi-
lar level of aspecific labeling was observed when cells were incubated with
rabbit  125I-immunoglobulin (Amersham Corp., Arlington Heights, IL).
The nonspecific binding on bloodstream forms equaled the total and non-
specific binding of 125I-TNF-a on procyclic forms. The binding data were
analyzed using the Prism program (GraphPad Software, San Diego, CA).
Both estimations of dissociation constant and the number of binding sites/
cell were obtained via a one site binding fit (hyperbola).
Nonradioactive TNF-a Binding Assays and
Affinity Measurements
Affinity measurements between TNF-a and total parasite lysate, as well
as between TNF-a and anti-TNF/TIP monoclonal antibodies, were per-
formed using the Iasys instrument with aminosilane cuvettes (Affinity
Sensors, Cambridge, UK) according to the procedures recommended by
the manufacturer. This type of measurement is based on the use of optical
biosensor technology (12).
The immobilization of TNF-a to aminosilane was performed as follows.
After initial preincubation of the aminosilane cuvettes with 10 mM phos-
phate buffer (pH 7.7), the homobifunctional crosslinker bis(sulfosuccin-
imidyl)suberate (BS3; Pierce, Rockford, IL) was added for 10 min to acti-
vate the surface. After reequilibration with phosphate buffer, TNF-a was
immobilized for 10 min at 100 mg/ml in phosphate buffer. Remaining ac-
tive sites were blocked with 1 M ethanolamine (pH 9.0). Unbound TNF-a
was removed by a single wash with 50 mM HCl. Specific binding resulted
in a 300–500 arcseconds laser reflection shift. All binding reactions were
performed at 278C in PBS. Different concentrations of total lysate and an-
tibodies were injected into the TNF-a–loaded cuvette. Association and
dissociation (after removal of the excess of unbound ligand) were mea-
sured (Iasys software; Affinity Sensors). Regeneration of the cuvette was
obtained by washing with 0.2% SDS in PBS.
The obtained data were analyzed by nonlinear regression, using the
FASTfit® software (Affinity Sensors). The association constant kass was
calculated for monoclonal anti-TNF/TIP antibodies using the slope of the
kon versus the antibody concentration. The dissociation constant kdiss was
directly measured from dissociation experiments. Dissociation constant
values equal kdiss/kass.
Binding and Uptake Studies
TNF-a–gold complexes were prepared using 10-nm gold beads (Amer-
sham Intl., Buckinghamshire, UK) following the prescribed protocol.
Briefly, the colloidal gold solution was equilibrated to pH 5.2, using 0.2 M
H3PO4, as the pI of recombinant murine TNF-a is 4.7. A minimal protect-
ing amount of TNF-a was added under continuous stirring for 2 min. Next,
the pH was increased to 9.0, using 0.2 M K2CO3. 10% BSA (pH 9.0) was
added to a final concentration of 1% after which the beads were pelleted
for 30 min using an SW41 rotor at 45,000 g. The supernatant was dis-
carded, and the pellet was washed once more at 50,000 g using a 10–30%
glycerol gradient in 1% BSA-20 mM Tris/HCl buffer (pH 8.2). The pellet
was collected and dialyzed overnight against the 1% BSA-Tris buffer. To
estimate the amount of TNF-a bound to the gold beads, the concentration
of nonbound TNF-a in all supernatant collected during the washings was
determined using a specific ELISA. The TNF-a–gold complexes were
stored in the 1% BSA-Tris buffer at an estimated concentration of 100
mg/ml TNF-a. Control beads were prepared in parallel using the same
condition, only without adding TNF-a at the start of the preparation.
To examine the binding and uptake of TNF-a, DE52-purified parasites
were washed and resuspended in PSG (pH 8.0) at a final cell density of
5 3 107/ml. After a 1 h equilibration period at 308C, 5 ml TNF-a–gold cor-
responding to z105 U (0.5 mg) of TNF-a was added, and the samples were
incubated for various periods of time. Subsequently, the parasites were
washed twice in PSG and fixed overnight in cacodylate buffer (pH 7.2) con-
taining 2.5% gluteraldehyde. Competition experiments were performed
using a 50-fold excess of unlabeled TNF-a, anti-TNF/TIP antibodies (10
mg/ml) or N,N9diacetyl-chitobiose (1 mg/ml), all added 1 h before incuba-
tion with TNF-a gold particles.
To analyze the influence of temperature on TNF-a uptake and TNF-
a–mediated lysis, parasites were washed twice after 1 h of TNF-a gold in-
cubation at 48, 178, or 308C. Afterwards, the parasites were further incu-
bated in fresh PSG equilibrated to the corresponding temperatures used
before the washings. After a total of 4 h of incubation, samples were fixed
overnight in cacodylate buffer (pH 7.2) containing 2.5% gluteraldehyde.
Further preparation of the samples for TEM analysis was performed as
described above.
Staining of Trypanosomal Lysosome Compartment
Trypanosomes were stained with LysoTrackerTM Red DN-99 (Molecular
Probes Europe BV, Leiden, The Netherlands) for up to 3 h in the absence
or presence of TNF-a. Cells were washed three times in PBS and fixed in
3% formaldehyde/0.5% gluteraldehyde. The LysoTrackerTM-stained par-
asites were observed on an Olympus BX50 microscope with an Uplanapo
1003 objective and a filter set for rhodamine fluorescence (excitation fil-
ter 510–550-nm long pass). The images were integrated during a fixed
number of video cycles (64 for fluorescence; 16 for transmitted light) on
an ImagePoint cooled CCD video camera (Photometrics Inc., Tucson, Ar-
izona) and transferred to an IBAS image analyzer (Kontron, Munich,
Germany). The region of interest was zoomed up twofold, and the gray
level distribution was normalized. Finally, the video screen was photo-
graphed. The image treatment parameters (all exposure times and gray
level scalings) were identical for the different experimental conditions.
In Vivo Antibody Treatment
F1 mice infected with 2,000 pleomorphic AnTat 1.1 parasites were given
one single intraperitoneal antibody injection 24 h before infection of 50 mg
purified antibody. During this treatment, the neutralizing monoclonal
anti–TNF-a antibody 1F3F3 (23) was used, as well as monoclonal and
polyclonal anti-TNF/TIP antibodies, directed against amino acid sequence
99–115 of mouse TNF-a. Control mice were treated with a monoclonal
antibody 15D3 against Bandeiraea siplicifolia BS-I isolectin B4 or with a
polyclonal anti-Con A antibody.
Generation of Anti-TNF/TIP Antibodies
Monoclonal anti-TNF/TIP antibodies. F1 mice were immunized intraperi-
toneally a first time at day 0 with 20 mg biotynilated mTIP peptide complexed
to avidin (25) in complete Freund’s adjuvant. The peptide used encom-
passes the 99–115 amino acid sequence (CGPKDTPEGAELKPWYC) of
mouse TNF-a. At day 21, a first intraperitoneal boost with 20 mg mTIP
peptide–avidin complex was given in incomplete Freund’s adjuvant, and
at day 42 a final intraperitoneal boost of 20 mg mTIP peptide–avidin com-
plex was given in PBS. At day 45 the animals were killed, and the spleen
was used to produce monoclonal antibodies. Mouse hybridomas were pre-
pared by fusion of immune mouse splenocytes to the HAT-sensitive mu-
rine myeloma cell line NSO with polyethylene glycol 4000 at a splenocyte–The Journal of Cell Biology, Volume 137, 1997 718
lymph node cell/NSO ratio of 10:1. Anti-mTIP monoclonal antibody-pro-
ducing hybrids were cloned twice by limiting dilution (0.6 cell/well) in
HAT medium. Screening of the anti-TIP monoclonal antibodies was done
on an mTIP peptide–streptavidin coating using casein–streptavidin as con-
trol, and purification of positive antibodies was done on a protein G col-
umn.
Polyclonal anti-TNF/TIP antibodies. The generation of the polyclonal
anti-TNF/TIP antibody has previously been described (25). In short, the
following procedure was followed: a rabbit was immunized subcutane-
ously at day 0 with a mixture of 1 mg/ml mTIP peptide–avidin complex in 1 ml
PBS and complete Freund’s adjuvant in a ratio of 1:1. At day 14 and 28, a
boost with 0.5 mg mTIP peptide–avidin complex in 1 ml PBS was given.
At day 77, a final boost was given of a mixture of 1 mg mTIP peptide–avi-
din complex in 1 ml PBS and incomplete Freund’s adjuvant in a ratio of 1:1.
One week later the rabbit was bled to obtain antipeptide serum. Poly-
clonal anti-mTIP antibodies were purified on a protein G affinity column.
Results
Ultrastructural Analysis of TNF-a Mediated
Lysis of T. brucei
Monomorphic AnTat 1.1 trypanosomes, isolated from the
blood of infected mice, were incubated up to 8 h at 308C in
PSG containing different concentrations of recombinant
murine TNF-a to follow trypanolysis as a function of time.
As shown in Fig. 1, a dose-dependent lysis of the parasites
was recorded, starting between 3 to 4 h of incubation and
reaching maximal levels after 5 h of incubation. No signifi-
cant lysis was recorded in the absence of TNF-a.
To study the morphological alterations that may occur
during trypanolysis, TNF-a–treated parasites were ana-
lyzed by TEM and flow cytometry (FSC analysis). Concor-
dant with the lysis experiments, TNF-a–induced morpho-
logical alterations occurred suddenly and progressed very
fast (Fig. 2). Indeed, after 1 to 3 h of incubation with TNF-a,
TEM analysis of the parasites revealed no major morpho-
logical changes (Fig. 2, Aa and Ab) and only a minor shift in
Figure 1. Lysis of bloodstream forms of T. brucei in function of
time (hours) and concentration of TNF-a: 1 U/ml (h), 10 U/ml
(j), 102 U/ml (s), 103 U/ml (d), 104 U/ml (e), 105 U/ml (r), and
106 U/ml (1). Trypanosomes were isolated from the blood of an
infected mouse and incubated for up to 8 h in PSG (pH 8.0) at
308C. Lysis assays were performed, and the percentage of lysis
was calculated as described in Materials and Methods. Each con-
centration of TNF-a was tested in at least three independent ex-
periments, and a representative experiment is shown.
FSC signals (z5%) was recorded by flow cytometric anal-
ysis after 3 h of incubation (Fig. 2 Cb). At this time point,
light microscopy analysis only indicated that a minor popu-
lation became nonmotile. After 4 h, an important part of the
trypanosome population analyzed in TEM manifested gross
morphological alterations in the presence of TNF-a. As
shown in Fig. 2 Ac, normal cells were observed in the vicin-
ity of cells with swollen organelles and ruptured plasma
membranes, reminiscent of an osmotic shock treatment.
Concomitantly, the FSC signal of a major part of the para-
sites shifted to the left (Fig. 2 Cc) and indicated a trypanol-
ysis of z40%. After 5 h of incubation, TEM analysis
showed a far progressed lysis, although some completely
intact cells were still found to be present (Fig. 2 Ad). FSC
analysis indicated a trypanolysis in the range of 85% (Fig.
2 Cd). Control parasites that were incubated in the ab-
sence of TNF-a and analyzed in TEM showed no changes
in morphology during the course of this experiment (Fig. 2
B,  a–d). During trypanolysis experiments, we never re-
corded a TNF-a specific lysis .85%, not even when incu-
bations were performed for periods up to 8 h. This obser-
vation indicates that within an apparently morphologically
homogenous population of monomorphic trypanosomes,
there is a heterogeneity with regard to TNF-a sensitivity.
Quantitative Analysis of TNF-a Binding on Live 
Trypanosomes and Trypanosome Lysate
To perform a quantitative analysis of the binding of TNF-a
to live monomorphic AnTat 1.1 trypanosomes, parasites
were incubated for 6 h at 48C with different molar concen-
trations of 125I-TNF-a. The results shown in Fig. 3 a con-
firm a specific binding of 125I-TNF-a on bloodstream form
trypanosomes. Competition binding experiments with 125I-
TNF-a in the presence of a 100-fold molar excess of cold
TNF-a showed a significant reduction of the parasite la-
beling. No specific TNF-a binding could be recorded on
procyclic parasites. Analysis of the specific binding data
obtained with bloodstream form trypanosomes (Fig. 3 b)
revealed an affinity constant of 37.2 6 14.8 nM and 1,558
6 302 TNF-a–specific binding sites. To confirm the bind-
ing of TNF-a to trypanosomes, a different method was
adopted. Using an optical biosensor, the direct binding of
TNF-a on total trypanosome lysate was measured (Fig. 4).
To test whether this binding reflects an interaction be-
tween the lectin-like activity of TNF-a (25) and glycosy-
lated trypanosome components, the trypanosome lysate
was treated with N-glycosidase F. This treatment strongly
reduced the binding of TNF-a to trypanosome lysate, in-
dicating that indeed a glycoprotein of bloodstream-form
trypanosomes binds TNF-a with high specificity via its
N-linked carbohydrate moiety.
Ultrastructural Analysis of TNF-a Binding and Uptake
To localize TNF-a binding sites on intact parasites and to
follow intracellular uptake of TNF-a, the cytokine was
conjugated to 10-nm colloidal gold particles and subse-
quently incubated with monomorphic AnTat 1.1 trypano-
somes at 308C. The bulk of the TNF-a–gold labeling was
localized in the flagellar pocket, where beads concentrated
in coated pits (Fig. 5 a, arrowhead). Sporadically, TNF-Magez et al. TNF-a–mediated Lysis of Trypanosoma brucei 719
a–gold particles were found in association with the flagel-
lum in the flagellar adhesion zone (Fig. 5, b and c), at the
entrance of the flagellar pocket, or in association with tiny
filamentous material at more distant regions of the flagel-
lum (Fig. 5 d). After binding, gold labeled TNF-a was endo-
cytosed through coated vesicles (Fig. 5 e). Coated vesicles
containing TNF-a–gold particles were often seen fusing
with larger electrolucent vacuoles wherein a cytoplasmic
area was invaginated, assuming cup-like shapes (Fig. 5 f)
which might look like rings in TEM (Fig. 5 g). Gold parti-
cles were also observed in tubular vesicular structures
(Fig. 5, h and i, top) but more frequently in dilatations of
the collecting membrane system described by Langreth
and Balber (21) which contain electron-dense material
(Fig. 5 i, lower part, j and k, middle). In parasites incubated
for longer periods (1 or 2 h), gold particles were also local-
Figure 3. Binding of 125I-
TNF-a to bloodstream-form
and procyclic trypanosomes.
(a) Bloodstream-form trypano-
somes (j) and procyclic try-
panosomes (h) were incu-
bated in the presence of
different molar concentra-
tions of 125I-TNF-a. Blood-
stream forms were also incu-
bated with 125I-TNF-a in the presence of a 100-fold molar excess of cold TNF-a (d). The number of bound molecules per cell was plotted
in function of the dose of 125I-TNF-a added. (b) Specific 125I-TNF-a binding to bloodstream-form trypanosomes. (c) Scatchard plot pre-
sentation of the same results. All the results shown are from one representative experiment.
Figure 2. Morphological
analysis by TEM and FSC of
TNF-a–induced trypanolysis
in function of time (a, 1 h, b,
3 h, c, 4 h, d, 5 h). Purified
trypanosomes were incu-
bated for various periods of
time in PSG (pH 8.0) in the
presence or absence of 105 U/
ml TNF-a. (A) TEM analysis
of TNF-a–treated T. brucei
parasites.  Swelling of or-
ganelles and lysis of para-
sites was recorded from 4 h
of incubation onwards (Ac).
(B) TEM analysis of non-
treated T. brucei parasites.
No lysis was observed. (C)
FSC of TNF-a–treated T.
brucei parasites. A major
shift to the left of the FSC
spectrum was observed from
4 h of incubation onwards
(Cc). Bar, 1 mm.The Journal of Cell Biology, Volume 137, 1997 720
ized in larger lysosome-like digestive vacuoles with more
(Fig. 5 k, top, and l) or less (Fig. 5 m) electron-lucent con-
tents. These vacuoles often sequestered areas of cytoplasm
remaining probably in connection with the surrounding
ground cytoplasm. As shown in Fig. 5 n, the vacuole from
a partially lysed parasite contains some gold particles (ar-
row) in addition to several such cytoplasmic areas.
When procyclic parasites were incubated with TNF-a–gold
particles, no binding of TNF-a was seen in the flagellar
pocket lumen, although rare formation of coated pits by
the membrane of the flagellar pocket was observed (Fig. 5
o). Consequently, no internalization of gold particles was
seen. As expected, no electron-dense inner layer, corre-
sponding to the VSGs in the bloodstream forms (compare
Fig. 5, o with e), was observed in procyclic coated pits.
When BSA–gold was used as a control, gold particles
were only found in some intracellular vacuoles but not in
coated pits or vacuoles. Competition experiments with an
excess of unconjugated TNF-a, reduced substantially the
cellular labeling, demonstrating that the binding of labeled
gold particles was TNF-a specific. Similar inhibition of bind-
ing of TNF-a–gold particles was observed when the parti-
cles were preincubated with anti-TNF/TIP antibodies or
N,N9diacetyl-chitobiose before incubation with the trypano-
somes (data not shown). These data are concordant with
our previous report that the lytic activity of TNF-a is me-
diated via the lectin-like TIP-domain (25).
Influence of Temperature and Intracellular pH on
TNF-a–mediated Lysis
Incubations of parasites at 48C with TNF-a–gold particles
yielded a very rare labeling of the lumen of the flagellar
pocket, and at this temperature no lysis was recorded,
not even after 24 h of incubation (results not shown). To
evaluate to which extent TNF-a–mediated trypanolysis is
temperature dependent, experiments with monomorphic
AnTat 1.1 trypanosomes were performed in parallel at dif-
ferent temperatures ranging from 378 to 178C. According
to the results shown in Fig. 6, the same maximal lysis was
obtained at 378, 328, or 298C, although the incubation time
required to reach the lytic plateau value increased slightly
with lower temperatures. At 268C, z50% of the maximal
TNF-a–mediated lysis was recorded, and practically no ly-
sis was observed at lower temperatures, not even when
samples were incubated up to 18 h.
TNF-a–induced morphological alterations which pre-
ceded lysis could only be observed by light microscopy
when incubation temperatures above 268C were used. At
308C in the absence of TNF-a, virtually no morphological
changes were observed after a 5 h incubation period (Fig.
7 a). However, in the presence of TNF-a, a large number
of cells were lysed, and most of the remaining cells showed
a clearly altered swollen morphology (Fig. 7 b). When in-
cubations were performed at 218C, no morphological dif-
ferences were observed between the cells incubated in the
absence and presence of TNF-a, as shown in Fig. 7, c and
d, respectively.
To analyze whether the insensitivity of the parasites to
TNF-a–mediated lysis recorded at lower temperatures re-
flects inefficient TNF-a binding and/or uptake, monomor-
phic trypanosomes were incubated during 1 h at 178 or
218C with TNF-a and subsequently washed and trans-
ferred to 308C for another 4 h of incubation. In a reversed
experimental setting, parasites were incubated with TNF-a
for 1 h at 308C and subsequently washed and transferred
to 178 or 218C. Control parasite populations were incu-
bated with TNF-a during 1 h at 178, 218, or 308C, washed,
and further incubated at their initial temperatures. The re-
sults, shown in Table I, clearly indicate that during the first
hour of incubation at 178 or 218C, enough TNF-a was
bound and internalized to yield a similar lysis as the lysis
recorded during continuous incubation at 308C. However,
lysis was blocked at 178 and 218C, even when the initial in-
cubation was performed at 308C.
Similar experiments were performed with TNF-a–gold
particles, i.e., trypanosomes were incubated for 1 h with
TNF-a–gold at 178 or 308C. Subsequently, the samples
were washed and reincubated during 4 h at the respective
temperatures. TEM analysis shown in Fig. 8 indicates that
parasites preincubated with TNF-a–gold particles during 1 h
at 308C, started lysing after a total incubation time of 4 h at
this temperature. (Fig. 8 a). In contrast, parasites preincu-
bated at 178C with TNF-a–gold particles, and kept at this
temperature for another 3 h, did not exhibit any sign of ly-
sis, although TNF-a–gold complexes were clearly internal-
ized (Fig. 8 b). At 308C, lysis was found to be preceded by
swelling of the vesicles containing TNF-a–gold particles and
of the mitochondria. Often, vesicles containing TNF-a–gold
particles exhibit large disruptions of their membranes (Fig.
8 a, arrow). Such events preceded prompt lysis. At 178C,
gold conjugates were found to be endocytosed, yet swell-
ing of TNF-a–collecting organelles or lysis of cells was not
recorded (Fig. 8 b).
The TEM analysis with TNF-a–gold particles strongly
suggests that the particles reach a lysosome-like compart-
ment as a final destination. Hence, the influence of pH ele-
Figure 4. The binding between TNF-a and total trypanosome ly-
sate (1) or N-glycosidase F–treated trypanosome lysate (2) was
analyzed using a biosensor. Sample injection was done at t 5 0,
and lysate was allowed to bind to a TNF-a coating on aminosi-
lane. Free lysate was removed by a PBS wash after 400 s, and dis-
sociation of the bound lysate was recorded. Both binding and dis-
sociation are measured as a shift in laser reflection angle (Arc
sec) as function of time (sec).Magez et al. TNF-a–mediated Lysis of Trypanosoma brucei 721
vation on trypanolysis was analyzed. As shown in Fig. 9 a,
the presence of NH4Cl during TNF-a incubations resulted
clearly in a dose-dependent inhibition of lysis. Maximal in-
hibitions of z90% were recorded using concentrations of
1 mM of NH4Cl or higher. Inhibition of TNF-a–mediated
lysis by 1 mM of NH4Cl was even recorded when the com-
pound was added 2 h after incubation with TNF-a (Fig.
9 b). Addition of NH4Cl after 3 h of TNF-a treatment did
not result in a substantial inhibition of lysis. Hence, an
acidic environment at the destination site of internalized
TNF-a appears to be required for TNF-a–mediated lysis.
TNF-a–mediated Lysis of T. brucei Is
Developmentally Regulated
To analyze whether different developmental stages of T.
Figure 5. Localization by TEM
of TNF-a binding and inter-
nalization at 308C by T. bru-
cei. TNF-a was conjugated to
10-nm gold particles as de-
scribed in Materials and
Methods. Cells were incu-
bated with TNF-a–gold par-
ticles at a concentration of
z105 U/ml. (a) TNF-a–gold
particles binding in the flagel-
lar pocket (fp) and concen-
trated in a coated pit formed
by its limiting membrane (ar-
rowhead). (b and c) TNF-a–
gold particles visible at and
near the contact zone be-
tween the flagellum and the
cell body. (d) TNF-a–gold
particles associated with the
flagellum. (e) TNF-a–gold
particles present in the lu-
men of the flagellar pocket
and two vesicles in the cyto-
plasm. (f) A coated vesicle
(arrowhead) in continuity
(arrow) with a vacuole con-
taining TNF-a–gold parti-
cles. (g) A vesicle containing
TNF-a–gold particles fusing
with a vacuole surrounding a
cytoplasmic area. (h) TNF-
a–gold particles present in
tubular vesicular structures
in close proximity to the
coated region of the flagellar
pocket membrane (arrow-
head). (i) A flattened vesicle
(top), and another one with a
more electron-dense content,
containing TNF-a–gold par-
ticles. (j) A dilatation of the
collecting membrane system
with electron-opaque lumen,
containing TNF-a–gold parti-
cles, seen in continuity (ar-
rows) with tubular structures.
(k) An electron-lucent vacu-
ole containing a few gold
particles and an electron-
opaque vacuole filled with
TNF-a–gold particles are vis-
ible near the parasite surface. (l) Two groups of TNF-a–gold particles present in a large electron-lucent vacuole surrounding a cyto-
plasmic area. (m) A large digestive vacuole containing dispersed gold particles. (n) A vacuole surrounding several cytoplasmic areas
and containing a group of gold particles (arrow). (o) Flagellar pocket of a procyclic form of T. brucei, whose limiting membrane forms a
coated pit (arrow). Observations a–j were done within the first of our TNF-a incubations. Observations k–o were made 2 h after the start
of the TNF-a incubation. Bars, 0.1 mm.The Journal of Cell Biology, Volume 137, 1997 722
brucei differ in sensitivity towards TNF-a, lysis experi-
ments were performed at 308C on both monomorphic and
pleomorphic AnTat 1.1 trypanosomes isolated at the ini-
tial phase of the parasitaemia and at the peak of the para-
sitaemia. As shown in Fig. 10, a and b, TNF-a–mediated
lysis of both monomorphic and pleomorphic trypano-
somes occurred only when these bloodstream parasites
were isolated at the peak of the parasitaemia, while no
lytic effect was observed when parasites were isolated at
the beginning of the infection. These results point again to
a heterogeneity of trypanosomes with respect to their sus-
ceptibility to TNF-a.
Taking into account the possible role of lysosome dam-
age as an early event in TNF-a–mediated trypanolysis,
both early (Fig. 11, a and b) and late stage trypanosomes
(Fig. 11, c and d) were stained with the fluorescent lyso-
some marker LysoTracker™ in the absence or presence of
TNF-a. Both the morphology of the parasites and the in-
tracellular localization of the marker were analyzed after 3 h
of incubation at 308C. First, Fig. 11 shows that lysed para-
sites (arrow) and parasites with altered morphology (ar-
rowhead) were only observed when late stage parasites
were treated with TNF-a (Fig. 11 Ad). No cell damage was
observed in the other samples (Fig. 11 A, a–c). Further-
more, Fig. 11 Aa (early stage) and Ac (late stage) show
that in the absence of TNF-a the lysosome marker was lo-
calized essentially in a single spot. In the presence of TNF-a,
a similar localization was still observed in the early stage
parasites (Fig. 11 Ab), while a diffuse staining was ob-
served in the late stage parasites (Fig. 11 Ad). These re-
sults suggest that TNF-a–mediated damage of the trypano-
somal lysosome-like organelles precedes total lysis of the
Figure 7. Morphological
characteristics of temperature
dependent TNF-a–mediated
lysis of bloodstream forms of
T. brucei. Lysis assays were
performed for 5 h at 308 and
218C as described in Materials
and Methods, using a TNF-a
concentration of 104 U/ml. (a)
At 308C no background lysis
was observed in the absence
of TNF-a. (b). In the pres-
ence of the cytokine, most
parasites were lysed after
the 5-h incubation period.
Remaining cells had a ghost-
like appearance (arrow) or
showed an abnormal swollen
morphology (arrowhead).
At 218C, no signs of altered
morphology or lysis were ob-
served in the absence (c) or
presence (d) of TNF-a. Bar,
20 mm.
Figure 6. TNF-a–mediated lysis of bloodstream forms of T. bru-
cei as function of temperature and time. A lysis assay was per-
formed using a TNF-a concentration of 104 U/ml. Samples were
kept at the indicated temperatures for various periods of time, up
till the moment that a plateau of TNF-a–specific lysis was reached.
The percentage of lysis was calculated as described in Materials
and Methods.
Table 1. TNF-mediated Trypanolysis in
Function of Temperature
Trypanosome treatment* Percentage of Trypanolysis‡
0 to 1 h 1 to 5 h TNF Controls
17°C 17°C 0 6 10  6  2
17°C 30°C 69 6 10 2 6 1
21°C 21°C 2 6 34  6  2
21°C 30°C 72 6 83  6  3
30°C 17°C 6 6 54  6  2
30°C 21°C 15 6 58  6  3
30°C 30°C 64 6 83  6  2
*Purified bloodstream form tyrpanosomes were preincubated for 1 h at 17°, 21°, or
30°C with 104 U/ml TNF-a, washed, and further incubated for 4 h as indicated. Con-
trol parasites were incubated under the same temperature conditions in the absence of
TNF-a.
‡The percentage of lysis was calculated as described in Materials and Methods after a
total incubation time of 5 h.
Table II. Influence of Anti-TNF Antibodies on Parasite 
Development in Trypanosoma-infected Mice
Antibody tested* Percentage increase in parasitaemia versus control‡
Cell line Blood Spleen Lymph nodes Peritoneum
1 E 12 174 6 74 28 6 4 34 6 8 87 6 32
24 C 11 219 6 69 34 6 2 35 6 4 105 6 31
anti-TIP (poly) 155 6 33 53 6 4 241 6 7 58 6 2
1F3F3 158 6 47 44 6 6 130 6 13 242 6 82
*Mice were infected intraperitoneally with pleomorphic T. brucei 24 h after intraperi-
toneal pretreatment with 50 mg of purified anti–TNF-a antibodies (10 mice/group).
1E12 and 24C11 are monoclonal antibodies directed against the TIP domain of TNF-a.
Anti-TIP (poly) is a polyclonal rabbit anti-TNF/TIP antibody. 1F3F3 is an neutralizing
monoclonal anti-TNF antibody.
‡Results are expressed as average percentage increase of parasitaemia (peak stage) as
compared to controls (animals treated with irrelevant monoclonal or polyclonal anti-
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cells and is developmentally regulated. To exclude the
possibility that the lack of lysosomal damage in early stage
trypanosomes was due to a lack of TNF-a uptake, these
parasites were also incubated with TNF-a–gold particles
for a total of 4 h at 308C. Again, none of the events preced-
ing trypanolysis were observed. As shown in Fig. 8 c, in
such parasites, TNF-a–gold particles were endocytosed
and subsequently collected in vesicles in a similar way as
Figure 8. Transmission electron microscopy analysis of intracellular uptake of TNF-a–gold particles and lysis of bloodstream forms of
T. brucei, isolated at the early stage and the peak of the parasitaemia. Cells were incubated with TNF-a–gold particles at a concentration
of z105 U/ml. (a) Peak stage parasites were incubated at 308C with TNF-a–gold particles for a total period of 4 h as described in Mate-
rials and Methods. TNF-a–gold particles are observed in a vacuole of an apparent intact parasite (inset, arrowhead), while other cells are
completely lysed. A large disruption in the membrane of the TNF-a–gold containing vesicle is indicated in the inset (arrow). m, mito-
chondria. (b) Peak stage parasites were incubated at 178C with TNF-a–gold particles for a total period of 4 h. TNF-a–gold particles are
observed in two vacuoles (center inset, arrowhead). No lysed cells were observed under these experimental conditions. (c) Early-stage T.
brucei bloodstream forms were incubated with TNF-a–gold particles for a total period of 4 h. TNF-a–gold particles are observed in a
vacuole surrounding a cytoplasmic area and in a smaller vesicle (bottom inset, arrowheads). No lysis was observed under these experi-
mental conditions. Bars: (a–c) 1 mm, (inset) 0.1 mm.The Journal of Cell Biology, Volume 137, 1997 724
observed with peak stage parasites (Fig. 8 a), but no subse-
quent swelling or lysis of the cells was observed. These re-
sults stress again that the uptake of TNF-a is a necessary
but not sufficient step to culminate in trypanolysis. To-
gether with the earlier observed lack of TNF-a endocyto-
sis by procyclic trypanosomes (Fig. 5 o) and the lack of
TNF-a–mediated trypanolysis of these forms (data not
shown), all results indicate that only late stage blood-
stream-form trypanosomes are TNF-a susceptible while
other forms are completely refractory to the trypanolytic
activity of TNF-a.
Influence of Monoclonal Anti–TNF-a Antibodies on 
TNF-a–mediated Trypanolysis In Vitro
To confirm the involvement of the previously described
lectin-like TNF/TIP domain in TNF-a–mediated trypano-
lysis (25), new monoclonal anti-TNF/TIP antibodies were
elicited against TNF/TIP peptides encompassing the lec-
tin-like activity of TNF-a. Antibodies were initially se-
lected based on their affinity in ELISA for the TIP pep-
tides used for immunization. For the selected monoclonal
antibodies 1E12 and 24C11, the affinity for native TNF-a
was further checked using the biosensor technique previ-
ously used to measure the affinity between trypanosome
lysate and TNF-a. The dissociation constant values re-
corded were 32.7 6 4.1 nM and 160.4 6 67.9 nM for 1E12
and 24C11, respectively. As shown in Fig. 12, both antibodies
and a previously described polyclonal rabbit anti-TIP anti-
body (25) were capable of neutralizing the trypanolytic ef-
fect of TNF-a in vitro (Fig. 12 a), while no inhibition activ-
ity was observed in a classical L929 TNF-a tumor lysis assay
(Fig. 12 b).
Influence of Anti–TNF-a Antibodies on T. brucei 
Development In Vivo
To evaluate the in vivo relevance of the in vitro TNF-a–medi-
ated  trypanolytic activity, T. brucei-infected mice were
treated with the above described anti-TNF/TIP antibodies.
We have reported earlier that the neutralizing monoclonal
anti–TNF-a antibody 1F3F3 increases the number of para-
sites present in the blood of infected mice, indicating that
TNF-a plays a controlling role during the normal course of
a  T. brucei parasitaemia (24). These experiments have
now been repeated with the above described monoclonal
and polyclonal anti-TNF/TIP antibodies. The results pre-
sented in Table II indicate that the in vivo treatment of T.
brucei infected mice with the TIP-specific monoclonal an-
tibodies 1E12 and 24C11 or the TIP-specific polyclonal an-
tibody, resulted in a dramatic increase in the number of
parasites during the first peak of the parasitaemia, as did
the treatment with the 1F3F3 monoclonal anti–TNF-a an-
tibody. The number of parasites, compared to control-
treated animals, increased in the bloodstream, the spleen,
the lymph nodes, and the peritoneal cavity. These results
suggest that in vivo, TNF-a exerts a growth limiting effect
on T. brucei via its lectin-like TIP domain and thus that the
herein described trypanolytic activity of TNF-a is physio-
logically relevant.
Discussion
The herein described data extends and corroborates our
previous findings on the trypanolytic activity of the cytokine
TNF-a on African trypanosomes (24–26). Furthermore, evi-
dence is provided for a direct involvement of TNF-a in the
growth regulation of T. brucei in its mammalian host.
TNF-a induces the lysis of trypanosomes via a process
that occurs suddenly and proceeds quickly after about 4 h
of incubation at 308C. This process of lysis is preceded by
cellular swelling as if the cells are subjected to an osmotic
shock. Hereby it should be emphasized that even when
high concentrations of TNF-a (up to 106 U/ml) were used
along with long incubation times (up to 8 h), a variable
proportion of trypanosomes (15–30%) was found to be re-
fractory towards TNF-a–mediated lysis. TNF-a lysis as-
says performed on monomorphic and pleomorphic AnTat
Figure 9. Inhibition of TNF-
a–mediated trypanolysis by
NH4Cl. Lysis assays were
carried out as described in
Materials and Methods. (a)
NH4Cl effects on lysis of T.
brucei as function of concen-
tration. Trypanosomes were
incubated at 308C in the pres-
ence of 104 U/ml TNF-a and
different concentrations
NH4Cl. (b) Effects of NH4Cl
on trypanolysis as function of
addition after preincubation
of parasites with TNF-a.
Trypanosomes were incu-
bated for 5 h at 308C in the
presence of 104 U/ml TNF-a.
Every hour NH4Cl was
added to one sample to a fi-
nal concentration of 1 mM.
The percentage of lysis inhibition was calculated compared to a
control lysis of 104 U/ml in the absence of NH4Cl.
Figure 10. Trypanolytic ac-
tivity of TNF-a on both
monomorphic and pleomor-
phic bloodstream forms of T.
brucei. Lysis assays were car-
ried out at 308C in the pres-
ence of different concentra-
tions of TNF-a as described
in Materials and Methods.
(a) Monomorphic T. brucei
parasites, isolated at the
early stage (j) and the peak
(h) of the parasitaemia, were
incubated with TNF-a. The
percentage of TNF-a–spe-
cific lysis was calculated as
described in Materials and
Methods. (b) Pleomorphic T.
brucei parasites, isolated at
the early stage (j) and peak
(h) of the parasitaemia, were
incubated with TNF-a, the
same way as the monomor-
phic parasites.Magez et al. TNF-a–mediated Lysis of Trypanosoma brucei 725
1.1 T. brucei parasites, isolated at the early parasitaemia
phase or at the peak of the parasitaemia, revealed that the
sensitivity of trypanosomes towards the lytic activity of
TNF-a is marked by a destruction of the trypanosomal ly-
sosome-like organelles and is developmentally regulated.
As TNF-a sensitivity is only acquired at the peak of the
parasitaemia, the minor population of nonsensitive trypano-
somes still present during the peak, might represent a pop-
ulation that did not yet reach this sensitive stage. Since
both monomorphic and pleomorphic trypanosomes, iso-
lated at the peak of the parasitaemia, were found to be
equally TNF-a sensitive, a differential TNF-a susceptibility
of long slenders versus short stumps is excluded. Further-
more, procyclic trypanosomes were found to be com-
pletely resistant towards TNF-a. This lack of TNF-a sensi-
tivity of the procyclic form is due to the lack of TNF-a
binding. Scatchard analysis of 125I-TNF-a binding on blood-
stream form trypanosomes revealed the presence of z1,600
TNF-a–binding molecules, while no binding could be ob-
served on procyclic parasites. Analyzing the binding be-
tween crude parasite lysates and TNF-a with an optical bio-
sensor confirmed the presence of a bloodstream stage
specific glycoprotein that is capable of binding TNF-a. Re-
moval of N-linked carbohydrate groups by N-glucosidase
F treatment strongly reduced the TNF-a binding. This ob-
servation confirms our previous finding that the lectin-like
domain of TNF-a is involved in the interaction with try-
panosomes (25).
Using TNF-a–gold particles, binding of TNF-a was lo-
calized mainly in the flagellar pocket. This binding could
be inhibited by cold TNF-a, anti-TNF/TIP antibodies, and
N,N9diacetyl-chitobiose, indicating that the binding of
gold particles is TNF-a specific and that the lectin-like do-
main of TNF-a is implicated in the binding process (25).
Hence, TNF-a interacts most probably with specific carbo-
hydrate components of the glycoprotein matrix enclosed
in the flagellar pocket. In fact, WGA, which displays a sim-
ilar carbohydrate specificity as TNF-a (35), was reported
to bind selectively to the flagellar pocket of T. brucei (6),
and we have shown that preincubation of T. brucei with
WGA inhibits the trypanolytic activity of TNF-a (25). We
found that TNF-a binds to the flagellar pocket and the
flagellar adhesion zone of bloodstream forms but not of
procyclic forms. Since the flagellar pocket glycoprotein com-
position was reported to differ between these two forms
(13), it may be that TNF-a binding oligosaccarides are ei-
ther absent or inaccessible in the flagellar membrane mi-
crodomains of procyclic trypanosomes.
After binding, TNF-a–gold particles were found to be
endocytosed through coated pits and vesicles. In blood-
stream-form trypanosomes, this pathway is used for in-
stance for the specific uptake of transferrin via its het-
erodimeric glycoprotein receptor (30). Coated vesicles
Figure 12. Specific inhibi-
tion of TNF-a–mediated lysis
of bloodstream forms of T.
brucei by anti-TIP antibod-
ies. (a) Freshly isolated
bloodstream-form trypano-
somes were incubated for up
to 8 h in PSG (pH 8.0) at
308C in the presence of dif-
ferent concentrations of
TNF-a. Trypanolysis was cal-
culated as described in Mate-
rials and Methods (j). Lysis
was inhibited by preincuba-
tion of TNF-a with three dif-
ferent TIP-specific antibod-
ies. The polyclonal antibody
(h) as well as both mono-
clonal antibodies 1E12 (d)
and 24C11 (s), all inhibited
the TNF-a–specific trypanol-
ysis to approximately the same extent. (b) None of the anti-TIP
antibodies inhibited TNF-a–mediated lysis of the TNF-a–sensi-
tive L929 cell line. The same symbols are used as in panel (a).
Figure 11. TNF-a–mediated lysis of bloodstream forms of T. bru-
cei is preceded by the destruction of their lysosome-like or-
ganelles. Both early and late stage trypanosomes were incubated
for 3 h at 308C with the lysosomal marker LysoTracker™ in the
absence or presence of 104 U/ml TNF-a. Early stage parasites
showed a normal morphology (Aa) and a localized lysosomal
staining (Ba). In the presence of TNF-a, both the morphology
(Ab) and lysosome staining (Bb) are unaltered. Late stage try-
panosomes also show a normal morphology (Ac) and lysosome
coloration (Bc) in the absence of TNF-a. In the presence of TNF-a
(Ad), some parasites are lysed (arrow) or have an abnormal mor-
phology (arrowhead) and show intracellular diffusion of the lyso-
some marker (Bd). Bar, 10 mm.The Journal of Cell Biology, Volume 137, 1997 726
containing TNF-a–gold were found to fuse with endo-
somes, and subsequently the particles were localized in tu-
bular vesicular extensions and more electron-dense cister-
nae of the collecting membrane system, all structures that
were extensively described in trypanosome bloodstream
forms (21). Finally, TNF-a–gold complexes were found in
digestive vacuoles connected to the collecting membrane
system. Globally, the intracellular pathway of endocytosed
TNF-a–gold complexes seems to involve similar structures
as those ones associated with the specific uptake of trans-
ferrin (30, 37), ferritin (21), high density lipoprotein (HDL;
14), and low density lipoprotein (LDL; 7), suggesting that
the final destination of the particles is lysosome-like diges-
tive vacuoles. Disruption of these collecting vacuoles was
frequently observed independent of whether native ligand
(TNF-a) or ligand conjugates (TNF-a–gold) were tested
in the trypanolysis assay.
The exact mechanism underlying TNF-a–mediated try-
panolysis is so far not defined. It is however clear that
binding and endocytosis of TNF-a is necessary but not suf-
ficient to induce trypanolysis. Indeed, endocytosis of TNF-a
is comparable in early and peak stage bloodstream forms,
yet only the peak-stage trypanosomes can be lysed by the
cytokine. Furthermore, while TNF-a uptake occurs at 308
as well as at 218 and 178C, its lytic activity appears to be
strongly temperature dependent and requires a tempera-
ture .258C. Hence an intracellular process that is develop-
mentally regulated and temperature sensitive determines
whether TNF-a–mediated lysis will or will not occur. In-
terestingly the threshold temperature required to inhibit
the lytic activity of TNF-a does not correspond to that one
preventing the fusion of endosomes and lysosomes (178C)
as documented for high density lipoprotein-mediated try-
panolysis (14). Rather, this 258C threshold temperature
corresponds exactly to the temperature at which a shift in
the membrane fluidity of trypanosomes occurs (20). Our
results further indicate that TNF-a–mediated trypanolysis
is pH dependent, since incubations with ammonium chlo-
ride strongly inhibit the lytic activity of TNF-a. Appar-
ently an acid pH is required to allow TNF-a to exert its in-
tracellular lytic activity. This observation may be related to
the documented pore-forming capacity of TNF-a (18). In-
deed at low pH, as a result of a conformational shift, TNF-a
is able to integrate into mammalian membranes resulting
in pore formation (3). Furthermore, the pore-forming ca-
pacity of TNF-a is mediated by the TIP-domain that is im-
plicated in the binding of TNF-a on trypanosomes (18).
The formation of ion-permeable channels could account
for the influx of cytosolic ions into TNF-a–collecting or-
ganelles, leading to the features of osmotic shock that
appear to be the primary event in TNF-a–mediated try-
panolysis. After organelle rupture, release of proteolytic
enzymes may accelerate the lytic process resulting in
prompt and complete lysis. Hereby mitochondria could be
among the first affected organelles, since circular cristae
were frequently observed in mitochondria of TNF-a–treated
cells. It should be emphasized that the proposed mecha-
nism of TNF-a is not confined to trypanosomes but could
also occur in mammalian cells. First, bypassing the classi-
cal TNF-a pathway involving the p55 and p75 TNF recep-
tors by microinjection of the cytokine leads to lysis of
mammalian cell lines such as L929 cells (36). Remarkably,
intracellular administration of TNF-a causes lysis of L929
cells after 4 h (similar for lysis of trypanosomes), while
when TNF-a is supplied in the medium, lysis of L929 cells
requires z20 h. Second, as already mentioned, TNF-a ex-
erts a pH dependent pore-forming activity on mammalian
membranes. Third, degeneration of mitochondrial struc-
tures is an early event in TNF-a–mediated lysis of mam-
malian cells (31). So intracellular TNF-a may exert similar
activities in trypanosomes and mammalian cells. Till now,
we cannot exclude the possibility that part of the intracel-
lular TNF-a is recycled to the membrane and exocytosed.
This possibility may account for our observation that clear
TNF-a concentration dependent plateau levels of lysis were
recorded, since partial recycling of intracellular TNF-a could
result in a steady-state situation.
The in vivo experiments with anti-TNF/TIP antibodies
finally demonstrate that TNF-a exerts a growth-control-
ling function on trypanosomes. This host cytokine, which
can be induced by the parasite itself (26, 38), apparently
binds specifically on trypanosomes and kills certain devel-
opmental stages of the parasite. Though we cannot yet ex-
plain why TNF-a sensitivity is developmentally regulated,
it is clear that trypanosomes are only lysed by TNF-a dur-
ing the peak stage of the parasitaemia. Important to men-
tion here is the recent report that TNF-a was shown to
abolish the growth promoting effect of IFN-g (2). Our find-
ings show that in addition to counteracting growth promo-
tion, TNF-a may contribute to limit the number of para-
sites in the bloodstream, peritoneal cavity, and lymphoid
organs by actively lysing trypanosomes.
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